OLPX vs SKIN

For growth investors, Olaplex Holdings, Inc.

(OLPX) is the stronger pick with 0. 1% revenue growth year-over-year, versus -10. 0% for The Beauty Health Company (SKIN). Analysts rate Olaplex Holdings, Inc. (OLPX) a "Hold" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Olaplex Holdings, Inc.

(OLPX) delivered a total return of -91. 7%, compared to -92. 9% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: SKIN returned -91. 6% versus OLPX's -91. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Olaplex Holdings, Inc.

(OLPX) is the lower-risk stock at 0. 84β versus The Beauty Health Company's 2. 00β — meaning SKIN is approximately 137% more volatile than OLPX relative to the S&P 500. On balance sheet safety, Olaplex Holdings, Inc. (OLPX) carries a lower debt/equity ratio of 40% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Olaplex Holdings, Inc.

(OLPX) is pulling ahead at 0. 1% versus -10. 0% for The Beauty Health Company (SKIN). On earnings-per-share growth, the picture is similar: The Beauty Health Company grew EPS 55. 6% year-over-year, compared to -134. 1% for Olaplex Holdings, Inc.. Over a 3-year CAGR, SKIN leads at -6. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Olaplex Holdings, Inc.

(OLPX) is the more profitable company, earning -2. 2% net margin versus -3. 2% for The Beauty Health Company — meaning it keeps -2. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OLPX leads at 1. 6% versus -6. 9% for SKIN. At the gross margin level — before operating expenses — OLPX leads at 69. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for SKIN: 42.

9% to $1. 30.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Olaplex Holdings, Inc.

(OLPX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 84)). The Beauty Health Company (SKIN) carries a higher beta of 2. 00 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (OLPX: -91. 7%, SKIN: -91. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (OLPX (Consumer Cyclical) and SKIN (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.